{"id":"W1539780911","doi":"10.1007/s10637-006-9022-7","title":"A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145","year":2006,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Adverse effect; Rash; Internal medicine; Multiple myeloma; Nausea; Vomiting; Clinical endpoint; Anemia; Gastroenterology; Phases of clinical research; Diarrhea; Pharmacokinetics; Pharmacology; Clinical trial; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001110633,0.001199012,0.002201369,0.0005643938,0.000456135,0.000815575,0.00110376,0.001172077,0.002965096],"category_scores_gemma":[0.0007172703,0.0005972835,0.001300584,0.000508171,0.0007444109,0.0006472462,0.0003139745,0.003328013,0.0007690914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001056945,"about_ca_system_score_gemma":0.001635376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003755022,"about_ca_topic_score_gemma":0.008336283,"domain_scores_codex":[0.9996619,0.0001407951,0.00001502253,0.00005148429,0.00003737334,0.00009339597],"domain_scores_gemma":[0.9995019,0.00007577126,0.00005542307,0.00003193497,0.00002908097,0.0003059003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7300462,0.05789541,0.0116138,0.0007567616,0.002439,0.0005770721,0.0003742915,0.003030255,0.04306946,0.0004777109,0.009887362,0.1398327],"study_design_scores_gemma":[0.6224509,0.3470026,0.02019998,0.00003144983,0.0007238527,0.000424406,0.00008305976,0.00146731,0.002744672,0.0001704176,0.00465939,0.00004203479],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884289,0.003885464,0.0005312228,0.0008243825,0.0002420899,0.001978045,0.001420708,0.0001281593,0.002560884],"genre_scores_gemma":[0.9851769,0.002990302,0.001674586,0.001276155,0.0002494399,0.001077876,0.003840711,0.00003086821,0.003683112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003755022,"threshold_uncertainty_score":0.009919226,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01286201718875107,"score_gpt":0.2673898610740773,"score_spread":0.2545278438853262,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}